共 78 条
- [1] Maggi C.A., Patacchini R., Rovero P., Giachetti A., Tachykinin receptors and tachykinin receptor antagonists, J Auton Pharmacol, 13, pp. 23-93, (1993)
- [2] Otsuka M., Yoshioka K., Neurotransmitter functions of mammalian tachykinins, Physiol Rev, 73, pp. 229-308, (1993)
- [3] Cascieri M.A., Huang R.R., Fong T.M., Cheung A.H., Sadowski S., Ber E., Strader C.D., Determination of the amino acid residues in substance P conferring selectivity and specificity for the rat neurokinin receptors, Mol Pharmacol, 41, pp. 1096-1099, (1992)
- [4] Von Euler U.S., Gaddum J.H., An unidentified depressor substance in certain tissue extracts, J Physiol, 72, pp. 74-89, (1931)
- [5] Brimijoin S., Lundberg J.M., Brodin E., Hokfelt T., Nilsson G., Axonal transport of substance P in the vagus and sciatic nerves of the guinea pig, Brain Res, 191, pp. 443-457, (1980)
- [6] Safieh-Garabedian B., Poole S., Allchorne A., Winter J., Woolf C.J., Contribution of interleukin-1β to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia, Br J Pharmacol, 115, pp. 1265-1275, (1995)
- [7] Brodin E., Gazelius B., Olgart L., Nilsson G., Tissue concentration and release of substance P-like immunoreactivity in the dental pulp, Acta Physiol Scand, 111, pp. 141-149, (1981)
- [8] Lembeck F., Holzer P., Substance P as neurogenic mediator of antidromic vasodilation and neurogenic plasma extravasation, Arch Pharmacol, 310, pp. 175-183, (1979)
- [9] Jancso N., Jancso-Gabor A., Szolcsanyi J., Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin, Br J Pharmacol, 31, pp. 138-151, (1967)
- [10] Buck S.H., Burcher E., The tachykinins